Clinical trial set to test two drugs for fast-growing Ebola outbreak
Reported bySTAT News ↗·Sourced by Goodlede
WHO-coordinated clinical trials testing two investigational drugs (remdesivir and MBP-134) against Bundibugyo ebolavirus begin next week in Central Africa, marking a direct therapeutic response to an active outbreak.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at STAT News
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Health
Magic Mushroom Compound Could Offer a New Approach to Treating Chronic Tinnitus
ScienceAlert · Caution
Health
Laurentian University sports psychology professor completes marathon after long COVID diagnosis
CBC News · Verified
Science
Telling one guiña from another: It's all about the angle
Mongabay · Verified